IBDEI347 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,49749,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,49749,1,2,0)
;;=2^96171
;;^UTILITY(U,$J,358.3,49749,1,3,0)
;;=3^Hlth Bhv Intv,Fam w/o Pt,Ea Addl 15 min
;;^UTILITY(U,$J,358.3,49750,0)
;;=96158^^192^2481^7^^^^1
;;^UTILITY(U,$J,358.3,49750,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,49750,1,2,0)
;;=2^96158
;;^UTILITY(U,$J,358.3,49750,1,3,0)
;;=3^Hlth Bhv Intv,Ind,1st 30 min
;;^UTILITY(U,$J,358.3,49751,0)
;;=96159^^192^2481^8^^^^1
;;^UTILITY(U,$J,358.3,49751,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,49751,1,2,0)
;;=2^96159
;;^UTILITY(U,$J,358.3,49751,1,3,0)
;;=3^Hlth Bhv Intv,Ind,Ea Addl 15 min
;;^UTILITY(U,$J,358.3,49752,0)
;;=B18.2^^193^2482^38
;;^UTILITY(U,$J,358.3,49752,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49752,1,3,0)
;;=3^Hepatitis C,Chr
;;^UTILITY(U,$J,358.3,49752,1,4,0)
;;=4^B18.2
;;^UTILITY(U,$J,358.3,49752,2)
;;=^5000548
;;^UTILITY(U,$J,358.3,49753,0)
;;=E11.9^^193^2482^23
;;^UTILITY(U,$J,358.3,49753,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49753,1,3,0)
;;=3^Diabetes Type 2
;;^UTILITY(U,$J,358.3,49753,1,4,0)
;;=4^E11.9
;;^UTILITY(U,$J,358.3,49753,2)
;;=^5002666
;;^UTILITY(U,$J,358.3,49754,0)
;;=E11.40^^193^2482^21
;;^UTILITY(U,$J,358.3,49754,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49754,1,3,0)
;;=3^DM Type 2 w/ Neuropathy
;;^UTILITY(U,$J,358.3,49754,1,4,0)
;;=4^E11.40
;;^UTILITY(U,$J,358.3,49754,2)
;;=^5002644
;;^UTILITY(U,$J,358.3,49755,0)
;;=E78.2^^193^2482^39
;;^UTILITY(U,$J,358.3,49755,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49755,1,3,0)
;;=3^Hyperlipidemia,Mixed
;;^UTILITY(U,$J,358.3,49755,1,4,0)
;;=4^E78.2
;;^UTILITY(U,$J,358.3,49755,2)
;;=^78424
;;^UTILITY(U,$J,358.3,49756,0)
;;=E78.5^^193^2482^40
;;^UTILITY(U,$J,358.3,49756,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49756,1,3,0)
;;=3^Hyperlipidemia,Unspec
;;^UTILITY(U,$J,358.3,49756,1,4,0)
;;=4^E78.5
;;^UTILITY(U,$J,358.3,49756,2)
;;=^5002969
;;^UTILITY(U,$J,358.3,49757,0)
;;=E66.3^^193^2482^57
;;^UTILITY(U,$J,358.3,49757,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49757,1,3,0)
;;=3^Overweight
;;^UTILITY(U,$J,358.3,49757,1,4,0)
;;=4^E66.3
;;^UTILITY(U,$J,358.3,49757,2)
;;=^5002830
;;^UTILITY(U,$J,358.3,49758,0)
;;=F17.200^^193^2482^50
;;^UTILITY(U,$J,358.3,49758,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49758,1,3,0)
;;=3^Nicotine Dependence,Unspec
;;^UTILITY(U,$J,358.3,49758,1,4,0)
;;=4^F17.200
;;^UTILITY(U,$J,358.3,49758,2)
;;=^5003360
;;^UTILITY(U,$J,358.3,49759,0)
;;=G43.909^^193^2482^48
;;^UTILITY(U,$J,358.3,49759,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49759,1,3,0)
;;=3^Migraine,Unspec
;;^UTILITY(U,$J,358.3,49759,1,4,0)
;;=4^G43.909
;;^UTILITY(U,$J,358.3,49759,2)
;;=^5003909
;;^UTILITY(U,$J,358.3,49760,0)
;;=H91.93^^193^2482^34
;;^UTILITY(U,$J,358.3,49760,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49760,1,3,0)
;;=3^Hearing Loss,Bilateral
;;^UTILITY(U,$J,358.3,49760,1,4,0)
;;=4^H91.93
;;^UTILITY(U,$J,358.3,49760,2)
;;=^5006944
;;^UTILITY(U,$J,358.3,49761,0)
;;=I10.^^193^2482^41
;;^UTILITY(U,$J,358.3,49761,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49761,1,3,0)
;;=3^Hypertension
;;^UTILITY(U,$J,358.3,49761,1,4,0)
;;=4^I10.
;;^UTILITY(U,$J,358.3,49761,2)
;;=^5007062
;;^UTILITY(U,$J,358.3,49762,0)
;;=I50.9^^193^2482^17
;;^UTILITY(U,$J,358.3,49762,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI347 3752 printed Dec 13, 2024@02:41:28 Page 2
IBDEI347 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,49749,1,0)
+2 ;;=^358.31IA^3^2
+3 ;;^UTILITY(U,$J,358.3,49749,1,2,0)
+4 ;;=2^96171
+5 ;;^UTILITY(U,$J,358.3,49749,1,3,0)
+6 ;;=3^Hlth Bhv Intv,Fam w/o Pt,Ea Addl 15 min
+7 ;;^UTILITY(U,$J,358.3,49750,0)
+8 ;;=96158^^192^2481^7^^^^1
+9 ;;^UTILITY(U,$J,358.3,49750,1,0)
+10 ;;=^358.31IA^3^2
+11 ;;^UTILITY(U,$J,358.3,49750,1,2,0)
+12 ;;=2^96158
+13 ;;^UTILITY(U,$J,358.3,49750,1,3,0)
+14 ;;=3^Hlth Bhv Intv,Ind,1st 30 min
+15 ;;^UTILITY(U,$J,358.3,49751,0)
+16 ;;=96159^^192^2481^8^^^^1
+17 ;;^UTILITY(U,$J,358.3,49751,1,0)
+18 ;;=^358.31IA^3^2
+19 ;;^UTILITY(U,$J,358.3,49751,1,2,0)
+20 ;;=2^96159
+21 ;;^UTILITY(U,$J,358.3,49751,1,3,0)
+22 ;;=3^Hlth Bhv Intv,Ind,Ea Addl 15 min
+23 ;;^UTILITY(U,$J,358.3,49752,0)
+24 ;;=B18.2^^193^2482^38
+25 ;;^UTILITY(U,$J,358.3,49752,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,49752,1,3,0)
+28 ;;=3^Hepatitis C,Chr
+29 ;;^UTILITY(U,$J,358.3,49752,1,4,0)
+30 ;;=4^B18.2
+31 ;;^UTILITY(U,$J,358.3,49752,2)
+32 ;;=^5000548
+33 ;;^UTILITY(U,$J,358.3,49753,0)
+34 ;;=E11.9^^193^2482^23
+35 ;;^UTILITY(U,$J,358.3,49753,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,49753,1,3,0)
+38 ;;=3^Diabetes Type 2
+39 ;;^UTILITY(U,$J,358.3,49753,1,4,0)
+40 ;;=4^E11.9
+41 ;;^UTILITY(U,$J,358.3,49753,2)
+42 ;;=^5002666
+43 ;;^UTILITY(U,$J,358.3,49754,0)
+44 ;;=E11.40^^193^2482^21
+45 ;;^UTILITY(U,$J,358.3,49754,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,49754,1,3,0)
+48 ;;=3^DM Type 2 w/ Neuropathy
+49 ;;^UTILITY(U,$J,358.3,49754,1,4,0)
+50 ;;=4^E11.40
+51 ;;^UTILITY(U,$J,358.3,49754,2)
+52 ;;=^5002644
+53 ;;^UTILITY(U,$J,358.3,49755,0)
+54 ;;=E78.2^^193^2482^39
+55 ;;^UTILITY(U,$J,358.3,49755,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,49755,1,3,0)
+58 ;;=3^Hyperlipidemia,Mixed
+59 ;;^UTILITY(U,$J,358.3,49755,1,4,0)
+60 ;;=4^E78.2
+61 ;;^UTILITY(U,$J,358.3,49755,2)
+62 ;;=^78424
+63 ;;^UTILITY(U,$J,358.3,49756,0)
+64 ;;=E78.5^^193^2482^40
+65 ;;^UTILITY(U,$J,358.3,49756,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,49756,1,3,0)
+68 ;;=3^Hyperlipidemia,Unspec
+69 ;;^UTILITY(U,$J,358.3,49756,1,4,0)
+70 ;;=4^E78.5
+71 ;;^UTILITY(U,$J,358.3,49756,2)
+72 ;;=^5002969
+73 ;;^UTILITY(U,$J,358.3,49757,0)
+74 ;;=E66.3^^193^2482^57
+75 ;;^UTILITY(U,$J,358.3,49757,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,49757,1,3,0)
+78 ;;=3^Overweight
+79 ;;^UTILITY(U,$J,358.3,49757,1,4,0)
+80 ;;=4^E66.3
+81 ;;^UTILITY(U,$J,358.3,49757,2)
+82 ;;=^5002830
+83 ;;^UTILITY(U,$J,358.3,49758,0)
+84 ;;=F17.200^^193^2482^50
+85 ;;^UTILITY(U,$J,358.3,49758,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,49758,1,3,0)
+88 ;;=3^Nicotine Dependence,Unspec
+89 ;;^UTILITY(U,$J,358.3,49758,1,4,0)
+90 ;;=4^F17.200
+91 ;;^UTILITY(U,$J,358.3,49758,2)
+92 ;;=^5003360
+93 ;;^UTILITY(U,$J,358.3,49759,0)
+94 ;;=G43.909^^193^2482^48
+95 ;;^UTILITY(U,$J,358.3,49759,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,49759,1,3,0)
+98 ;;=3^Migraine,Unspec
+99 ;;^UTILITY(U,$J,358.3,49759,1,4,0)
+100 ;;=4^G43.909
+101 ;;^UTILITY(U,$J,358.3,49759,2)
+102 ;;=^5003909
+103 ;;^UTILITY(U,$J,358.3,49760,0)
+104 ;;=H91.93^^193^2482^34
+105 ;;^UTILITY(U,$J,358.3,49760,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,49760,1,3,0)
+108 ;;=3^Hearing Loss,Bilateral
+109 ;;^UTILITY(U,$J,358.3,49760,1,4,0)
+110 ;;=4^H91.93
+111 ;;^UTILITY(U,$J,358.3,49760,2)
+112 ;;=^5006944
+113 ;;^UTILITY(U,$J,358.3,49761,0)
+114 ;;=I10.^^193^2482^41
+115 ;;^UTILITY(U,$J,358.3,49761,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,49761,1,3,0)
+118 ;;=3^Hypertension
+119 ;;^UTILITY(U,$J,358.3,49761,1,4,0)
+120 ;;=4^I10.
+121 ;;^UTILITY(U,$J,358.3,49761,2)
+122 ;;=^5007062
+123 ;;^UTILITY(U,$J,358.3,49762,0)
+124 ;;=I50.9^^193^2482^17
+125 ;;^UTILITY(U,$J,358.3,49762,1,0)
+126 ;;=^358.31IA^4^2
